It is a chemicals private limited company based in Kolhapur, Maharashtra, India, established in 2020.
2020 | Kolhapur, Maharashtra, India | ActiveRennova Pharmaceuticals Private Limited, a active private limited company, was established on 11 November 2020 in Kolhapur, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239PN2020PTC195946. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sagar Raghunath Gajabar (Director), Pravin Patil (Director), Sanjay Vitthal Patil (Director). Past directors included Manesh Davhid Hegade. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Sagar Raghunath Gajbar 14/1/1 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, 416004.
U24239PN2020PTC195946
195946
11 November 2020
₹0.50 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Rennova Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sagar Raghunath Gajabar | Director | 11 Nov 2020 | Current |
| Pravin Patil | Director | 11 Nov 2020 | Current |
| Sanjay Vitthal Patil | Director | 11 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Rennova Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rennova Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rennova Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rennova Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rennova Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rennova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Rennova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
Progress on Sagar Raghunath Gajabar was appointed as a Director was appointed as a Director on 11 Nov 2020 & has been associated with this company since 5 years 2 months . was documented.
Progress on Pravin Patil was appointed as a Director was appointed as a Director on 11 Nov 2020 & has been associated with this company since 5 years 2 months . was documented.
Progress on Sanjay Vitthal Patil was appointed as a Director was appointed as a Director on 11 Nov 2020 & has been associated with this company since 5 years 2 months . was documented.
The activity Rennova Pharmaceuticals Private Limited was registered on 11 Nov 2020 with Roc Pune & aged 5 years 2 months as per MCA records. was completed.
The CIN of Rennova Pharmaceuticals Private Limited is U24239PN2020PTC195946.
Rennova Pharmaceuticals Private Limited is headquartered at C/O Sagar Raghunath Gajbar 14/1/1 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, 416004.
Rennova Pharmaceuticals Private Limited was incorporated on 11 November 2020.
The current directors of Rennova Pharmaceuticals Private Limited are
The primary industry of Rennova Pharmaceuticals Private Limited is Chemicals.
Rennova Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rennova Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX